Your browser doesn't support javascript.
loading
Efficacy and safety of combined use of aliskiren and valsartan in patients with hypertension: a randomised, double-blind trial.
Oparil, Suzanne; Yarows, Steven A; Patel, Samir; Fang, Hui; Zhang, Jack; Satlin, Andrew.
Afiliação
  • Oparil S; Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: soparil@uab.edu.
  • Yarows SA; Chelsea Internal Medicine/IHA, Chelsea, MI, USA.
  • Patel S; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Fang H; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Zhang J; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
  • Satlin A; Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA.
Lancet ; 370(9583): 221-229, 2007 Jul 21.
Article em En | MEDLINE | ID: mdl-17658393
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrazóis / Valina / Renina / Fumaratos / Amidas / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2007 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tetrazóis / Valina / Renina / Fumaratos / Amidas / Hipertensão / Anti-Hipertensivos Tipo de estudo: Clinical_trials Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2007 Tipo de documento: Article